Insmed

INSM

INSM Insmed NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    INSM Chart
    See on advanced chart >

    About

    Insmed Incorporated is a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life-threatening. The company's lead product candidate, ARIKACE or liposomal amikacin for...
    • Highlight
      A biopharmaceutical company that developing products commonly used for the treatment of Mycobacterium avium complex lung disease
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/01/2000
    • Established Date
      11/29/1999
    • Full-time Employees
      912
    • Address
      700 US Highway 202/206 Bridgewater New Jersey 08807
    • Tel
      1-908-9779900
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-04-17 09:17:37